You just read:

Rigel Receives Positive CHMP Opinion for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe

News provided by

Rigel Pharmaceuticals, Inc.

Nov 15, 2019, 07:30 ET